Patrick Burnett - 18 Aug 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Reporting Person's Title: Senior Vice President and Chief Medical Officer
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Patrick Burnett
Issuer symbol
ARQT
Transactions as of
18 Aug 2023
Transactions value $
-$11,302
Form type
4
Filing time
22 Aug 2023, 13:24:31 UTC
Previous filing
08 Mar 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale -$2,115 -300 -0.5% $7.05 59,662 21 Aug 2023 Direct F1
transaction ARQT Common Stock Sale -$9,187 -1,305 -2.2% $7.04 58,357 21 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Remarks:

Reporting Person's Title: Senior Vice President and Chief Medical Officer